HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 364 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $309,420 | +5.9% | 8,100 | 0.0% | 0.03% | +11.5% |
| Q2 2023 | $292,167 | -5.6% | 8,100 | 0.0% | 0.03% | -10.3% |
| Q1 2023 | $309,339 | -32.9% | 8,100 | 0.0% | 0.03% | -37.0% |
| Q4 2022 | $460,890 | +57.3% | 8,100 | +9.5% | 0.05% | +43.8% |
| Q3 2022 | $293,000 | -10.1% | 7,400 | 0.0% | 0.03% | -5.9% |
| Q2 2022 | $326,000 | +10.5% | 7,400 | 0.0% | 0.03% | +36.0% |
| Q1 2022 | $295,000 | -1.0% | 7,400 | 0.0% | 0.02% | 0.0% |
| Q4 2021 | $298,000 | -1.0% | 7,400 | 0.0% | 0.02% | -13.8% |
| Q3 2021 | $301,000 | -10.4% | 7,400 | 0.0% | 0.03% | +11.5% |
| Q2 2021 | $336,000 | +8.7% | 7,400 | 0.0% | 0.03% | -16.1% |
| Q1 2021 | $309,000 | -2.2% | 7,400 | 0.0% | 0.03% | -13.9% |
| Q4 2020 | $316,000 | – | 7,400 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |